Frederick J. Livesey

Tennis Court Road
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Investigating how changes in the levels of kinesins impact neuronal health in Drosophila and human iPSC-derived neurons AD model.

Investigating how changes in the levels of kinesins impact neuronal health in Drosophila and human iPSC-derived neurons AD model.

Journal: Open biology

Published: August 22, 2025

A phenotypic screen for novel small molecules that correct tau-mediated pathologies in human frontotemporal dementia neurons.

A phenotypic screen for novel small molecules that correct tau-mediated pathologies in human frontotemporal dementia neurons.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 07, 2025

Synaptotoxic effects of extracellular tau are mediated by its microtubule-binding region.

Synaptotoxic effects of extracellular tau are mediated by its microtubule-binding region.

Journal: Acta neuropathologica

Published: February 07, 2025

Tau uptake by human neurons depends on receptor LRP1 and kinase LRRK2.

Tau uptake by human neurons depends on receptor LRP1 and kinase LRRK2.

Journal: The EMBO journal

Published: January 27, 2025

Mislocalization of nucleic acids is a convergent and targetable mechanism in Alzheimer's disease and frontotemporal dementia.

Mislocalization of nucleic acids is a convergent and targetable mechanism in Alzheimer's disease and frontotemporal dementia.

Journal: Cell reports

Published: December 10, 2024

NAT10 inhibition corrects nuclear defects in tau mutant human neurons and extends lifespan in a Drosophila tauopathy model.

NAT10 inhibition corrects nuclear defects in tau mutant human neurons and extends lifespan in a Drosophila tauopathy model.

Journal: iScience

Published: October 19, 2024

APP antisense oligonucleotides are effective in rescuing mitochondrial phenotypes in human iPSC-derived trisomy 21 astrocytes.

APP antisense oligonucleotides are effective in rescuing mitochondrial phenotypes in human iPSC-derived trisomy 21 astrocytes.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 04, 2024

Clearance of beta-amyloid and tau aggregates is size dependent and altered by an inflammatory challenge.

Clearance of beta-amyloid and tau aggregates is size dependent and altered by an inflammatory challenge.

Journal: Brain communications

Published: July 06, 2024

Patient-derived tau and amyloid-β facilitate long-term depression in vivo: role of tumour necrosis factor-α and the integrated stress response.

Patient-derived tau and amyloid-β facilitate long-term depression in vivo: role of tumour necrosis factor-α and the integrated stress response.

Journal: Brain communications

Published: January 23, 2024

APP antisense oligonucleotides reduce amyloid-β aggregation and rescue endolysosomal dysfunction in Alzheimer's disease.

APP antisense oligonucleotides reduce amyloid-β aggregation and rescue endolysosomal dysfunction in Alzheimer's disease.

Journal: Brain : a journal of neurology

Published: September 11, 2023

Synchronisation of apical constriction and cell cycle progression is a conserved behaviour of pseudostratified neuroepithelia informed by their tissue geometry.

Synchronisation of apical constriction and cell cycle progression is a conserved behaviour of pseudostratified neuroepithelia informed by their tissue geometry.

Journal: Developmental biology

Published: October 17, 2022

The role of contactin-associated protein-like 2 in neurodevelopmental disease and human cerebral cortex evolution.

The role of contactin-associated protein-like 2 in neurodevelopmental disease and human cerebral cortex evolution.

Journal: Frontiers in molecular neuroscience

Published: August 11, 2022

Showing 1-12 of 50

Last Updated: 09/26/2026